HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lakics, V. Articles by Vogel, S. N. Search for Related Content PubMed PubMed Citation Articles by Lakics, V. Articles by Vogel, S. N.

Inhibition of LPS-induced Cytokines by Bcl-x_L in a Murine Macrophage Cell Line¹

Viktor Lakics^2,*, Andrei E. Medvedev^2,*, Seiji Okada and Stefanie N. Vogel^3,*

^* Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814; and Department of Developmental Genetics, Chiba University Graduate School of Medicine, Chiba, Japan

The antiapoptotic molecule Bcl-x_L has been implicated in the differentiation and survival of activated macrophages in inflammatory conditions. In this report, the role of Bcl-x_L in LPS-induced cytokine gene expression and secretion was studied. Bcl-x_L-transfected RAW 264 macrophages were protected from gliotoxin-induced apoptosis, indicating the presence of functional Bcl-x_L. Overexpression of Bcl-x_L in this macrophage cell line was also associated with a marked inhibition of LPS-induced TNF-, JE/monocyte chemoattractant protein 1, and macrophage inflammatory protein 2 secretion. Inhibition of LPS-induced cytokine secretion was paralleled by a decrease in levels of steady-state mRNA for the above cytokines and for IL-1ß. Decreased production of TNF- in Bcl-x_L transfectants was not due to increased mRNA degradation, as the mRNA half-lives were the same in Bcl-x_L transfectants and control macrophages. Although the composition of NF-B complexes detected by EMSA and supershift analysis in nuclear lysates derived from Bcl-x_L transfectants and control cells was indistinguishable, LPS-induced inhibitory B degradation, as well as NF-B binding and AP-1 activation, were slightly decreased by ectopic expression of Bcl-x_L. More strikingly, LPS-induced phosphorylation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase was strongly repressed by Bcl-x_L overexpression, offering a possible mechanism for the inhibition of LPS-induced cytokine production. These data provide the first evidence for a novel role for Bcl-x_L as an anti-inflammatory mediator in macrophages.

This article has been cited by other articles:

				S. Giorgini, D. Trisciuoglio, C. Gabellini, M. Desideri, L. Castellini, C. Colarossi, U. Zangemeister-Wittke, G. Zupi, and D. Del Bufalo Modulation of bcl-xL in Tumor Cells Regulates Angiogenesis through CXCL8 Expression Mol. Cancer Res., August 1, 2007; 5(8): 761 - 771. [Abstract] [Full Text] [PDF]

				J. Niu, A. Azfer, and P. E. Kolattukudy Monocyte-specific Bcl-2 expression attenuates inflammation and heart failure in monocyte chemoattractant protein-1 (MCP-1)-induced cardiomyopathy Cardiovasc Res, July 1, 2006; 71(1): 139 - 148. [Abstract] [Full Text] [PDF]

				S. K. Sukumaran, S. K. Selvaraj, and N. V. Prasadarao Inhibition of Apoptosis by Escherichia coli K1 Is Accompanied by Increased Expression of BclXL and Blockade of Mitochondrial Cytochrome c Release in Macrophages Infect. Immun., October 1, 2004; 72(10): 6012 - 6022. [Abstract] [Full Text] [PDF]

				H. Assaf, H. Azouri, and M. Pallardy Ochratoxin A Induces Apoptosis in Human Lymphocytes through Down Regulation of Bcl-xL Toxicol. Sci., June 1, 2004; 79(2): 335 - 344. [Abstract] [Full Text] [PDF]

				A. Iwata, V. M. Stevenson, A. Minard, M. Tasch, J. Tupper, E. Lagasse, I. Weissman, J. M. Harlan, and R. K. Winn Over-Expression of Bcl-2 Provides Protection in Septic Mice by a trans Effect J. Immunol., September 15, 2003; 171(6): 3136 - 3141. [Abstract] [Full Text] [PDF]

				J. S. Park, J. Arcaroli, H.-K. Yum, H. Yang, H. Wang, K.-Y. Yang, K.-H. Choe, D. Strassheim, T. M. Pitts, K. J. Tracey, et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein Am J Physiol Cell Physiol, April 1, 2003; 284(4): C870 - C879. [Abstract] [Full Text] [PDF]

				B. W. Jarvis, T. H. Harris, N. Qureshi, and G. A. Splitter Rough Lipopolysaccharide from Brucella abortus and Escherichia coli Differentially Activates the Same Mitogen-Activated Protein Kinase Signaling Pathways for Tumor Necrosis Factor Alpha in RAW 264.7 Macrophage-Like Cells Infect. Immun., December 1, 2002; 70(12): 7165 - 7168. [Abstract] [Full Text] [PDF]

				O. Lopez-Franco, Y. Suzuki, G. Sanjuan, J. Blanco, P. Hernandez-Vargas, Y. Yo, J. Kopp, J. Egido, and C. Gomez-Guerrero Nuclear Factor-{kappa}B Inhibitors as Potential Novel Anti-Inflammatory Agents for the Treatment of Immune Glomerulonephritis Am. J. Pathol., October 1, 2002; 161(4): 1497 - 1505. [Abstract] [Full Text] [PDF]

				L. Ziegler-Heitbrock The p50-homodimer mechanism in tolerance to LPS Innate Immunity, June 1, 2001; 7(3): 219 - 222. [PDF]

				J. Lee, J. Hur, P. Lee, J. Y. Kim, N. Cho, S. Y. Kim, H. Kim, M.-S. Lee, and K. Suk Dual Role of Inflammatory Stimuli in Activation-induced Cell Death of Mouse Microglial Cells. INITIATION OF TWO SEPARATE APOPTOTIC PATHWAYS VIA INDUCTION OF INTERFERON REGULATORY FACTOR-1 AND CASPASE-11 J. Biol. Chem., August 24, 2001; 276(35): 32956 - 32965. [Abstract] [Full Text] [PDF]